Staging and assessment of lymph node involvement by 18F- fluorodeoxyglucose-positron emission tomography in invasive extramammary Paget's disease

Dermatologic Surgery

Volumn 31, Issue 5, 2005, Pages 595-598

  Aoyagi, Satoru ^a   Sato Matsumura, Kazuko C ^a   Shimizu, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUMAN TISSUE; INGUINAL REGION; INTERMETHOD COMPARISON; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; PAGET SKIN DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCINTIGRAPHY; TREATMENT OUTCOME; DIFFERENTIAL DIAGNOSIS; MALE GENITAL TRACT TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

AGED; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; GENITAL NEOPLASMS, MALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PAGET'S DISEASE, EXTRAMAMMARY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 20844448198     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042728-200505000-00022     Document Type: Article

References (8)

1. 18F-fluorodeoxyglucose positron emission tomography in melanoma patients. Cancer 2001;91:1530-42.
2. Jung J, Cho SB, Yun M, et al. Metastatic malignant proliferating trichilemmal tumor detected by positron emission tomography. Dermatol Surg 2003;29:872-4.
3. Shapiro M, Yun M, Junkins-Hopkins JM, et al. Assessment of tumor burden and treatment response by 18F-fluorodeoxyglucose injection and positron emission tomography in patient with cutaneous T- and B-cell lymphomas. J Am Acad Dermatol 2002;47:623-8.
4. Nguyen BAD. Positron emission tomographic imaging of Merkel cell carcinoma. Clin Nucl Med 2002;27:922-3.
5. Zollo JD, Zeitouni NC. The Roswell Park Cancer Institute experience with extramammary Paget's disease. Br J Dermatol 2000;142:59-65.
6. Crippa F, Leutner M, Belli F, et al. Which kind of lymph node metastases can FDG PET detected? A clinical study in melanoma. J Nucl Med 2000;41:1491-4.
7. 18FDG PET imaging versus sentinel node detection. Oncologist 2002;7:271-8.
8. Longo MI, Lazaro P, Bueno C, et al. Fluorodeoxyglucose-positron emission tomography imaging versus sentinel node biopsy in the primary staging of melanoma patients. Dermatol Surg 2003;29:245-8.